These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25965958)

  • 1. Highly Stereoselective Synthesis of Lamivudine (3TC) and Emtricitabine (FTC) by a Novel N-Glycosidation Procedure.
    Caso MF; D'Alonzo D; D'Errico S; Palumbo G; Guaragna A
    Org Lett; 2015 Jun; 17(11):2626-9. PubMed ID: 25965958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities.
    Scaglione F; Berrino L
    Int J Antimicrob Agents; 2012 Jun; 39(6):458-63. PubMed ID: 22269860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides.
    Sabini E; Hazra S; Konrad M; Lavie A
    J Med Chem; 2007 Jun; 50(13):3004-14. PubMed ID: 17530837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-continuous multi-step synthesis of lamivudine.
    Mandala D; Chada S; Watts P
    Org Biomol Chem; 2017 Apr; 15(16):3444-3454. PubMed ID: 28362445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (±)-Emtricitabine and (±)-Lamivudine by Chlorotrimethylsilane-Sodium Iodide-Promoted Vorbrüggen Glycosylation.
    Mear SJ; Nguyen LV; Rochford AJ; Jamison TF
    J Org Chem; 2022 Mar; 87(5):2887-2897. PubMed ID: 35030006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.
    Feng JY; Myrick FT; Margot NA; Mulamba GB; Rimsky L; Borroto-Esoda K; Selmi B; Canard B
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):89-107. PubMed ID: 16440988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles.
    Behrens G; Maserati R; Rieger A; Domingo P; Abel F; Wang H; Pearce G
    Antivir Ther; 2012; 17(6):1011-20. PubMed ID: 22910324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
    Marcelin AG; Charpentier C; Wirden M; Landman R; Valantin MA; Simon A; Katlama C; Yeni P; Descamps D; Aubron-Olivier C; Calvez V
    J Antimicrob Chemother; 2012 Jun; 67(6):1475-8. PubMed ID: 22371439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of tenofovir/emtricitabine and abacavir/lamivudine on human leukocyte recruitment.
    De Pablo C; Orden S; Calatayud S; Martí-Cabrera M; Esplugues JV; Alvarez A
    Antivir Ther; 2012; 17(8):1615-9. PubMed ID: 22954798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.
    Martin A; Bloch M; Amin J; Baker D; Cooper DA; Emery S; Carr A
    Clin Infect Dis; 2009 Nov; 49(10):1591-601. PubMed ID: 19842973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial.
    Curran A; Martinez E; Podzamczer D; Lonca M; Barragan P; Crespo M; Falco V; Vidal-Sicart S; Imaz A; Martinez M; Gatell JM; Ribera E
    Antivir Ther; 2012; 17(4):711-8. PubMed ID: 22374987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.
    Moyle GJ; Stellbrink HJ; Compston J; Orkin C; Arribas JR; Domingo P; Granier C; Pearce H; Sedani S; Gartland M;
    Antivir Ther; 2013; 18(7):905-13. PubMed ID: 23899468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside-Based Self-Assembling Drugs for Localized Drug Delivery.
    Skilling KJ; Stocks MJ; Kellam B; Ashford M; Bradshaw TD; Burroughs L; Marlow M
    ChemMedChem; 2018 Jun; 13(11):1098-1101. PubMed ID: 29570948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients.
    Rousseau FS; Wakeford C; Mommeja-Marin H; Sanne I; Moxham C; Harris J; Hulett L; Wang LH; Quinn JB; Barry DW;
    J Infect Dis; 2003 Dec; 188(11):1652-8. PubMed ID: 14639535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
    Smith KY; Patel P; Fine D; Bellos N; Sloan L; Lackey P; Kumar PN; Sutherland-Phillips DH; Vavro C; Yau L; Wannamaker P; Shaefer MS;
    AIDS; 2009 Jul; 23(12):1547-56. PubMed ID: 19542866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001.
    Maeda K; Desai DV; Aoki M; Nakata H; Kodama EN; Mitsuya H
    Antivir Ther; 2014; 19(2):179-89. PubMed ID: 24162098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (125) I-lamivudine and (125) I-lamivudine-ursodeoxycholic acid codrug.
    Motaleb MA; Abo-Kul M; Ibrahim SM; Saad SM; Arafat M
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):451-3. PubMed ID: 27561199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interactions between apricitabine and other deoxycytidine analogues.
    Bethell R; De Muys J; Lippens J; Richard A; Hamelin B; Ren C; Collins P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2948-53. PubMed ID: 17517847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chirality Control in Enzyme-Catalyzed Dynamic Kinetic Resolution of 1,3-Oxathiolanes.
    Hu L; Ren Y; Ramström O
    J Org Chem; 2015 Aug; 80(16):8478-81. PubMed ID: 26237578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
    Hill A; Sawyer W
    HIV Med; 2009 Oct; 10(9):527-35. PubMed ID: 19785663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.